(Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | |
---|---|---|---|---|---|---|---|---|---|
Turnover | 18.93%460.09M | 33.40%820.54M | 38.03%386.84M | 35.22%615.1M | 33.03%280.25M | 37.32%454.89M | --210.67M | 57.89%331.26M | --209.8M |
Operating income | 18.93%460.09M | 33.40%820.54M | 38.03%386.84M | 35.22%615.1M | 33.03%280.25M | 37.32%454.89M | 210.67M | 57.89%331.26M | 209.8M |
Cost of sales | -18.68%-314.66M | -31.41%-562.4M | -36.41%-265.13M | -23.62%-427.97M | -22.83%-194.36M | -37.18%-346.2M | ---158.23M | -53.86%-252.36M | ---164.02M |
Operating expenses | -18.68%-314.66M | -31.41%-562.4M | -36.41%-265.13M | -23.62%-427.97M | -22.83%-194.36M | -37.18%-346.2M | -158.23M | -53.86%-252.36M | -164.02M |
Gross profit | 19.48%145.43M | 37.95%258.15M | 41.70%121.72M | 72.16%187.13M | 63.81%85.9M | 37.77%108.69M | 52.44M | 72.34%78.9M | 45.78M |
Selling expenses | -26.89%-6.47M | -24.81%-12.53M | -45.89%-5.1M | -35.69%-10.04M | -28.68%-3.5M | -141.12%-7.4M | ---2.72M | -87.59%-3.07M | ---1.64M |
Administrative expenses | -34.11%-38.91M | -22.15%-86.78M | 4.72%-29.02M | -142.36%-71.04M | -192.42%-30.45M | -35.55%-29.31M | ---10.41M | -63.78%-21.63M | ---13.2M |
Impairment and provision | -103.58%-16.28M | -227.41%-31.48M | -99.70%-8M | -94.56%-9.62M | -70.38%-4M | 34.07%-4.94M | ---2.35M | -37.39%-7.5M | ---5.46M |
-Other impairment is provision | -103.58%-16.28M | -227.41%-31.48M | -99.70%-8M | -94.56%-9.62M | -70.38%-4M | 34.07%-4.94M | ---2.35M | -37.39%-7.5M | ---5.46M |
Special items of operating profit | 186.91%6.42M | 150.06%12.95M | -15.10%2.24M | 202.04%5.18M | 204.04%2.64M | -7.25%1.72M | --867K | -0.22%1.85M | --1.85M |
Operating profit | 10.20%90.19M | 38.09%140.31M | 61.81%81.85M | 47.78%101.61M | 33.73%50.58M | 41.60%68.75M | 37.82M | 77.62%48.56M | 27.34M |
Financing cost | -799.28%-1.25M | -1,199.16%-1.55M | -183.67%-139K | -526.32%-119K | -444.44%-49K | -35.71%-19K | ---9K | 99.37%-14K | ---2.23M |
Special items of earning before tax | 104.04%4K | -108.88%-117K | -106.20%-99K | 405.80%1.32M | 3,029.41%1.6M | ---431K | --51K | ---- | ---- |
Earning before tax | 8.99%88.94M | 34.86%138.64M | 56.55%81.61M | 50.51%102.81M | 37.66%52.13M | 40.71%68.3M | 37.87M | 93.33%48.54M | 25.11M |
Tax | 1.92%-20.29M | -4.95%-34.46M | -30.37%-20.69M | -81.53%-32.84M | -70.16%-15.87M | -41.70%-18.09M | ---9.33M | -88.85%-12.77M | ---6.76M |
After-tax profit from continuing operations | 12.70%68.65M | 48.90%104.18M | 68.01%60.92M | 39.34%69.97M | 27.05%36.26M | 40.36%50.21M | 28.54M | 94.98%35.78M | 18.35M |
Earning after tax | 12.70%68.65M | 48.90%104.18M | 68.01%60.92M | 39.34%69.97M | 27.05%36.26M | 40.36%50.21M | 28.54M | 94.98%35.78M | 18.35M |
Minority profit | 250.71%2.97M | -18.49%3.7M | 39.93%848K | --4.54M | --606K | ---- | ---- | ---- | ---- |
Profit attributable to shareholders | 9.34%65.68M | 53.58%100.48M | 68.49%60.07M | 30.29%65.43M | 24.92%35.65M | 40.36%50.21M | 28.54M | 94.98%35.78M | 18.35M |
Basic earnings per share | 10.00%0.11 | 14.29%0.16 | 25.00%0.1 | 27.27%0.14 | -100.00%0.08 | -100.00%0.11 | 285K | 95.63%358K | 183K |
Diluted earnings per share | 10.00%0.11 | 14.29%0.16 | 25.00%0.1 | 27.27%0.14 | -100.00%0.08 | -100.00%0.11 | 285K | 95.63%358K | 183K |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data